nancy lynn snyderman MD

Insider Reports History

Location
Princeton, NJ
Signature
/s/ Shantale Greenson, attorney-in-fact for Nancy Snyderman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by nancy lynn snyderman MD:

Company Role Class Num Shares Value Price $ Report Date Ownership
Alkermes plc. Director Ordinary Shares 20,783 $631,387 $30.38 31 May 2025 By the Snyderman Trust
Alkermes plc. Director Non Qualified Stock Option (Right to Buy) 17,492 $537,354 $30.72 31 May 2024 Direct
Alkermes plc. Director Ordinary Shares 10,728 $328,384 $30.61 31 May 2025 Direct
Future Health ESG Corp. Director Common stock, par value $0.0001 per share 11,262 $134,130 $11.91 24 Oct 2021 Indirect
Future Health ESG Corp. Director Common stock, par value $0.0001 per share 11,250 $133,988 $11.91 24 Oct 2021 Direct
Axonics, Inc. Director Common Stock 0 $0 $71.00 15 Nov 2024 Direct
Axonics, Inc. Director Stock Option (Right to Buy) 0 $0 $49.96 15 Nov 2024 Direct
Lyra Therapeutics, Inc. Director Restricted Stock Units 32,000 14 May 2025 Direct
Lyra Therapeutics, Inc. Director Stock Option 30,000 13 Jun 2024 Direct
Alkermes plc. Director Non Qualified Stock Option (Right to Buy) 13,474 21 May 2025 Direct
Alkermes plc. Director Restricted Stock Unit Award 0 31 May 2025 Direct

Insider Reports Filed by nancy lynn snyderman MD

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALKS Alkermes plc. 31 May 2025 3 -$58,894 4 Director 02 Jun 2025, 16:32
ALKS Alkermes plc. 21 May 2025 2 $0 4 Director 23 May 2025, 17:59
LYRA Lyra Therapeutics, Inc. 14 May 2025 1 $0 4 Director 16 May 2025, 16:30
/report/000156218024007710-snyderman-nancy-lynn-md-2024-11-15 Axonics, Inc. 15 Nov 2024 3 -$1,714,386 4 Director 15 Nov 2024, 09:00
/report/000156218024007659-snyderman-nancy-lynn-md-2024-11-07 Axonics, Inc. 07 Nov 2024 1 $0 4 Director 12 Nov 2024, 19:01
ALKS Alkermes plc. 29 Jun 2024 3 -$35,306 4 Director 01 Jul 2024, 17:01
LYRA Lyra Therapeutics, Inc. 13 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:10
ALKS Alkermes plc. 31 May 2024 13 +$114,611 4 Director 04 Jun 2024, 17:01
ALKS Alkermes plc. 07 Jul 2023 3 -$42,728 4 Director 10 Jul 2023, 20:35
LYRA Lyra Therapeutics, Inc. 30 Jun 2023 1 $0 4 Director 05 Jul 2023, 21:46
ALKS Alkermes plc. 29 Jun 2023 2 $0 4 Director 30 Jun 2023, 16:36
/report/000156218023005532-snyderman-nancy-lynn-md-2023-06-26 Axonics, Inc. 26 Jun 2023 1 $0 4 Director 28 Jun 2023, 20:21
/report/000156218022006264-snyderman-nancy-lynn-md-2022-08-18 Axonics, Inc. 18 Aug 2022 1 $0 4 Director 22 Aug 2022, 20:13
ALKS Alkermes plc. 07 Jul 2022 2 $0 4 Director 08 Jul 2022, 16:23
LYRA Lyra Therapeutics, Inc. 16 Jun 2022 1 $0 4 Director 21 Jun 2022, 16:05
ALKS Alkermes plc. 14 Jun 2022 3 -$18,897 4 Director 16 Jun 2022, 16:58
ALKS Alkermes plc. 04 Mar 2022 1 +$10,005 4 Director 08 Mar 2022, 15:13
ALKS Alkermes plc. 02 Dec 2021 3 -$29,605 4 Director 03 Dec 2021, 20:26
/report/000110465921129991-snyderman-nancy-lynn-md-2021-10-24 Future Health ESG Corp. 24 Oct 2021 2 $0 4 Director 26 Oct 2021, 16:27
/report/000156218021006778-snyderman-nancy-lynn-md-2021-10-22 Axonics, Inc. 22 Oct 2021 1 $0 4 Director 02 Nov 2021, 21:16
/report/000110465921116450-snyderman-nancy-lynn-md-2021-09-14 Future Health ESG Corp. 14 Sep 2021 1 +$27,351 4 Director 16 Sep 2021, 17:17
/report/000110465921114332-snyderman-nancy-lynn-md-2021-09-09 Future Health ESG Corp. 09 Sep 2021 0 $0 3 Director 09 Sep 2021, 21:29
ALKS Alkermes plc. 14 Jun 2021 2 $0 4 Director 16 Jun 2021, 16:28
LYRA Lyra Therapeutics, Inc. 26 May 2021 1 $0 4 Director 28 May 2021, 18:24
ALKS Alkermes plc. 20 May 2021 3 -$30,776 4 Director 21 May 2021, 16:38